Hairpin Oligonucleotide Can Functionalize Gold Nanorods for in Vivo Application Delivering Cytotoxic Nucleotides and Curcumin: A Comprehensive Study in Combination with Near-Infrared Laser-Reference-Cited by-同舟云学术

Hairpin Oligonucleotide Can Functionalize Gold Nanorods for in Vivo Application Delivering Cytotoxic Nucleotides and Curcumin: A Comprehensive Study in Combination with Near-Infrared Laser

Published:2020-11-02 Issue:44 Volume:5 Page:28463-28474
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Das Upasana¹,Bhuniya Avishek²,Roy Anup K.³,Gmeiner William H.⁴,Ghosh Supratim¹^ORCID

Affiliation:

1. Department of Anti-Cancer Drug Development and Chemotherapy, Chittaranjan National Cancer Institute, 37 S.P. Mukherjee Road, Kolkata 700026, India

2. Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, 37 S.P. Mukherjee Road, Kolkata 700026, India

3. Department of Pathology, Nil Ratan Sircar Medical College and Hospital, Kolkata 700014, India

4. Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, United States

Funder

Department of Science and Technology, Ministry of Science and Technology

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsomega.0c02288

Reference65 articles.

1. MULTIMODALITY TREATMENT OF CANCER

2. Multimodality therapy for Pancoast tumor

3. Telehealth allows for clinical trial participation and multimodality therapy in a rural patient with stage 4 non-small cell lung cancer

4. Radical multimodality therapy for malignant pleural mesothelioma

5. Stuck in the middle of chemoresistance and metastasis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Prodrug and Nanodelivery Strategies to Improve the Treatment of Colorectal Cancer with Fluoropyrimidine Drugs;Pharmaceutics;2024-05-29

2. Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects;Cancer Drug Resistance;2023